# Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

> **NCT04565600** · PHASE2 · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 144 (actual)

## Conditions studied

- Pain Syndrome

## Interventions

- **DRUG:** Etoricoxib

## Key facts

- **NCT ID:** NCT04565600
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2021-04-22
- **Final completion:** 2021-06-28
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04565600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04565600, "Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04565600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*